GRCh38/hg38 22q13.31(chr22:43841416-44192863)x3 AND See cases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 12, 2011
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000052857.4

Allele description [Variation Report for GRCh38/hg38 22q13.31(chr22:43841416-44192863)x3]

GRCh38/hg38 22q13.31(chr22:43841416-44192863)x3

Genes:

LOC130067638:ATAC-STARR-seq lymphoblastoid active region 19196 [Gene]
LOC130067643:ATAC-STARR-seq lymphoblastoid active region 19197 [Gene]
LOC130067644:ATAC-STARR-seq lymphoblastoid active region 19198 [Gene]
LOC130067645:ATAC-STARR-seq lymphoblastoid active region 19199 [Gene]
LOC130067646:ATAC-STARR-seq lymphoblastoid active region 19200 [Gene]
LOC130067647:ATAC-STARR-seq lymphoblastoid active region 19201 [Gene]
LOC130067648:ATAC-STARR-seq lymphoblastoid active region 19202 [Gene]
LOC130067649:ATAC-STARR-seq lymphoblastoid active region 19203 [Gene]
LOC130067650:ATAC-STARR-seq lymphoblastoid active region 19204 [Gene]
LOC130067651:ATAC-STARR-seq lymphoblastoid active region 19205 [Gene]
LOC130067652:ATAC-STARR-seq lymphoblastoid active region 19206 [Gene]
LOC130067653:ATAC-STARR-seq lymphoblastoid active region 19207 [Gene]
LOC130067654:ATAC-STARR-seq lymphoblastoid active region 19208 [Gene]
LOC130067639:ATAC-STARR-seq lymphoblastoid silent region 13860 [Gene]
LOC130067640:ATAC-STARR-seq lymphoblastoid silent region 13861 [Gene]
LOC130067641:ATAC-STARR-seq lymphoblastoid silent region 13862 [Gene]
LOC130067642:ATAC-STARR-seq lymphoblastoid silent region 13863 [Gene]
LOC130067655:ATAC-STARR-seq lymphoblastoid silent region 13864 [Gene]
LOC130067656:ATAC-STARR-seq lymphoblastoid silent region 13866 [Gene]
LOC126863162:MED14-independent group 3 enhancer GRCh37_chr22:44293320-44294519 [Gene]
SAMM50:SAMM50 sorting and assembly machinery component [Gene - OMIM - HGNC]
LOC114004363:Sharpr-MPRA regulatory region 15126 [Gene]
LOC121627950:Sharpr-MPRA regulatory region 5125 [Gene]
PARVB:parvin beta [Gene - OMIM - HGNC]
PARVG:parvin gamma [Gene - OMIM - HGNC]
PNPLA3:patatin like phospholipase domain containing 3 [Gene - OMIM - HGNC]
PNPLA5:patatin like phospholipase domain containing 5 [Gene - OMIM - HGNC]
SULT4A1:sulfotransferase family 4A member 1 [Gene - OMIM - HGNC]
TRU-TCA2-1:tRNA-SeC (anticodon TCA) 2-1 [Gene - HGNC]

Variant type:

copy number gain

Cytogenetic location:

22q13.31

Genomic location:

Preferred name:

GRCh38/hg38 22q13.31(chr22:43841416-44192863)x3

HGVS:

NC_000022.11:g.(?_43841416)_(44192863_?)dup
NC_000022.10:g.(?_44237296)_(44588743_?)dup
NC_000022.9:g.(?_42568629)_(42920076_?)dup

Links:

dbVar: nssv581079; dbVar: nsv531572

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Homologene neighbors for GEO Profiles (Select 121717519) (0)
GEO Profiles

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000080211	GeneDx	criteria provided, single submitter (Kaminsky et al. (Genet Med. 2011))	Uncertain significance (Aug 12, 2011)	not provided	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000080211

GeneDx

criteria provided, single submitter

(Kaminsky et al. (Genet Med. 2011))

Uncertain significance
(Aug 12, 2011)

not provided

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	not provided	yes	1	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, et al.

Genet Med. 2011 Sep;13(9):777-84. doi: 10.1097/GIM.0b013e31822c79f9.

PubMed [citation]

PMID:: 21844811
PMCID:: PMC3661946

Details of each submission

From GeneDx, SCV000080211.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	not provided	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: Oct 14, 2023

ClinVar

Relating variation to medicine